✦ LIBER ✦

Phase II study of intravenous menogaril in advanced ovarian carcinoma

✍ Scribed by Sessa, Cristiana; Kaye, Stan B.; Renard, Josette; ten Bokkel Huinink, Wim; Cavalli, Franco

Book ID: 122339017
Publisher: Elsevier Science
Year: 1989
Weight: 204 KB
Volume: 25
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(89)90214-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II evaluation of menogaril in pati

Phase II evaluation of menogaril in patients with advanced cervical carcinoma

✍ Harry J. Long; Harry S. Wieand; John F. Foley; Robert D. Niedringhaus; John A. L 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 170 KB

Fourteen patients with advanced/recurrent squamous cell carcinoma of the uterine cervix received menogaril, 200 mg/m 2 by one hour intravenous infusion at four-week intervals. No objective regressions were observed. Median time to progression was less than two months and median survival was seven mo

Phase II trial of menogaril in advanced

Phase II trial of menogaril in advanced colorectal cancer

✍ Eduard E. Holdener; Wim W. Bokkel Huinink; Genevieve Decoster; Christian Ludwig; 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 262 KB

Menogaril, a new semisynthetic anthracycline antibiotic, was administered to 35 patients with advanced colorectal cancer. The drug was infused over 2 hr at a dose of 160 mg/sqm or 200 mg/sqm repeated every 4 weeks. Twenty-seven patients were evaluable for response and no objective responses were ach

Phase II study of 5-Aza-2′-deoxycytidine

Phase II study of 5-Aza-2′-deoxycytidine in advanced ovarian carcinoma

✍ Sessa, Cristiana; Ten Bokkel Huinink, Wim; Stoter, Gerrit; Renard, Josette; Cava 📂 Article 📅 1990 🏛 Elsevier Science ⚖ 202 KB

Phase II trial of vinblastine in advance

Phase II trial of vinblastine in advanced ovarian carcinoma

✍ Gregory P. Sutton; John A. Blessing; Mark D. Adelson; Parviz Hanjani 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 231 KB

A phase II trial of vinblastine in patients with refractory epithelial ovarian adenocarcinoma of the ovary was conducted by the Gynecologic Oncology Group (GOG) between March 9, 1988 and July 7, 1988. Vinblastine was administered in a dose of 9 mg/m2 intravenously every three weeks until disease pro

cis-dichlorodiammineplatinum (II) and he

cis-dichlorodiammineplatinum (II) and hexamethylmelamine in advanced ovarian carcinoma: A phase II study

✍ Lund, Birthe; Aabo, Kristian; Rørth, Mikael; Hansen, Heine Høi 📂 Article 📅 1982 🏛 Elsevier Science ⚖ 474 KB

Phase II study of weekly intravenous men

Phase II study of weekly intravenous menogaril in the treatment of recurrent astrocytomas in adults

✍ David J. Stewart; Herman Hugenholtz; Vasco F. DaSilva; Brian G. Benoit; Michael 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 435 KB

Twenty patients with astrocytomas recurrent after surgery + radiation were treated on a phase II protocol of the new anthracycline derivative menogaril 115 mg/m 2 administered intravenously once per week. Sixteen patients were evaluable for treatment efficacy. No patient achieved a major therapeutic